These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 12052040)

  • 21. Endocannabinoids in cognition and dependence.
    Lichtman AH; Varvel SA; Martin BR
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):269-85. PubMed ID: 12052042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of endogenous cannabinoids in synaptic signaling.
    Freund TF; Katona I; Piomelli D
    Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of the cannabinoid and opioid systems in the modulation of nociception.
    Welch SP
    Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
    Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
    Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
    Ashton JC; Milligan ED
    Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The cannabinoid system and pain: a new therapeutic avenue?].
    Desroches J; Beaulieu P
    Rev Med Suisse; 2008 Jun; 4(162):1505-6, 1508-10, 1512-3. PubMed ID: 18649597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid transmission and pain perception.
    Martin BR; Lichtman AH
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):447-61. PubMed ID: 9974177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
    Nackley AG; Makriyannis A; Hohmann AG
    Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
    Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptors and pain.
    Pertwee RG
    Prog Neurobiol; 2001 Apr; 63(5):569-611. PubMed ID: 11164622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stressed-out endogenous cannabinoids relieve pain.
    Vaughan CW
    Trends Pharmacol Sci; 2006 Feb; 27(2):69-71. PubMed ID: 16364458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.
    Fride E
    J Neuroendocrinol; 2008 May; 20 Suppl 1():75-81. PubMed ID: 18426504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gastrointestinal pharmacology of cannabinoids: an update.
    Coutts AA; Izzo AA
    Curr Opin Pharmacol; 2004 Dec; 4(6):572-9. PubMed ID: 15525546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids in cancer pain management.
    Huskey A
    J Pain Palliat Care Pharmacother; 2006; 20(3):43-6. PubMed ID: 16931481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.